Capital Investment Advisory Services, LLC Amarin Corp Plcuk Transaction History

Capital Investment Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$4.78 - $8.26 $130,016 - $224,672	-27,200 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$4.0 - $21.53 $108,800 - $585,616	27,200 New	27,200 $109,000
Q4 2019 Feb 04, 2020	SELL	$13.94 - $24.12 $61,336 - $106,128	-4,400 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$13.89 - $23.16 $1,389 - $2,316	100 Added 2.33%	4,400 $67,000
Q2 2019 Aug 08, 2019	BUY	$16.27 - $20.51 $58,572 - $73,836	3,600 Added 514.29%	4,300 $78,000
Q4 2018 Feb 04, 2019	BUY	$12.41 - $22.98 $8,687 - $16,086	700 New	700 $10,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.